Dr Hadir Rostom (Egypt)
BPharm, Exec. Mgmt. (Harvard)
Lecturer, MSA University | WHO Consultant | Chair, ISoP Egypt Chapter

Dr Hadir Rostom is an international expert in pharmacovigilance with more than 24 years of experience in the pharmaceutical sector, including 14 years dedicated to drug safety. She currently lectures at MSA University in Egypt and serves as a WHO Consultant for Regulatory System Strengthening, supporting national authorities worldwide in developing and enhancing pharmacovigilance systems in line with WHO benchmarks. As an independent pharmacovigilance consultant and lead auditor, she advises on global compliance and system optimization across the pharmaceutical industry.

Dr Rostom co-founded and led the Egyptian Pharmacovigilance Center and contributed to developing Good Pharmacovigilance Practice guidelines across Arab countries, as well as integrating PV education within academia in Egypt. She is a member of the WHO Advisory Committee on the Safety of Medicinal Products (ACSoMP), a member of the ISoP Scientific Board, Chair of the ISoP Egypt Chapter, and Co-chair of the ISoP 2025 Cairo Annual Meeting Scientific Committee.

Her vision for pharmacovigilance emphasizes proactive, data-informed safety systems supported by global collaboration, AI integration, and equitable regulatory harmonization, particularly in underserved regions.